| Mr James A Olson, MD | |
|
222 N 2nd St Ste 102, Boise, ID 83702-6129 | |
| (208) 424-0280 | |
| Not Available |
| Full Name | Mr James A Olson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 29 Years |
| Location | 222 N 2nd St Ste 102, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912992249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M-9825 (Idaho) | Secondary |
| 208C00000X | Colon & Rectal Surgery | M-9825 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Entity Name | Center For Colorectal Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740319409 PECOS PAC ID: 6406948769 Enrollment ID: O20070816000690 |
News Archive
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Roll Call reports: "Senators may keep slogging through debate on their health care overhaul until the day before Thanksgiving, according to an adjournment resolution the House approved Wednesday. That measure provided for the Senate to adjourn Friday — or next Wednesday. The House is set to break on Thursday or Friday of this week." The Senate must first vote on a motion to proceed - to move the bill to the floor (Newmyer, 11/18).
The human leucocyte antigen-C and killer immunoglobin-like receptor genotypes are associated with response to interferon-based therapy in patients with chronic hepatitis B virus infection positive for hepatitis B e antigen, say researchers.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
A transitional stroke clinic developed by doctors and nurse practitioners at Wake Forest Baptist Medical Center reduced 30-day readmission rates by 48 percent, according to a study published in the April 28 online issue of the journal Stroke.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr James A Olson, MD 222 N 2nd St Ste 102, Boise, ID 83702-6129 Ph: () - | Mr James A Olson, MD 222 N 2nd St Ste 102, Boise, ID 83702-6129 Ph: (208) 424-0280 |
News Archive
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Roll Call reports: "Senators may keep slogging through debate on their health care overhaul until the day before Thanksgiving, according to an adjournment resolution the House approved Wednesday. That measure provided for the Senate to adjourn Friday — or next Wednesday. The House is set to break on Thursday or Friday of this week." The Senate must first vote on a motion to proceed - to move the bill to the floor (Newmyer, 11/18).
The human leucocyte antigen-C and killer immunoglobin-like receptor genotypes are associated with response to interferon-based therapy in patients with chronic hepatitis B virus infection positive for hepatitis B e antigen, say researchers.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
A transitional stroke clinic developed by doctors and nurse practitioners at Wake Forest Baptist Medical Center reduced 30-day readmission rates by 48 percent, according to a study published in the April 28 online issue of the journal Stroke.
› Verified 4 days ago